Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)
This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funde, ongoing interventional clinical trials.
The ongoing parent project has to be an interventional
clinical trial that can provide a cohort of well-characterized patients, infrastructure, data, and biological samples.
Applications submitted in response to this FOA will undergo an accelerated review and award process.
Each application must include a clear description of the ancillary studys mechanistic rationale and premise, and a timeline to demonstrate that the parent project has adequate time left to accommodate the proposed ancillary study.
In addition, applicants must justify the time-sensitive nature of the ancillary study and the need for an expedited review and award process.
Applicants must also document permission from the parent project to use the patient cohorts, data, and biological materials.
The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects.
Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.
The ongoing parent project has to be an interventional
clinical trial that can provide a cohort of well-characterized patients, infrastructure, data, and biological samples.
Applications submitted in response to this FOA will undergo an accelerated review and award process.
Each application must include a clear description of the ancillary studys mechanistic rationale and premise, and a timeline to demonstrate that the parent project has adequate time left to accommodate the proposed ancillary study.
In addition, applicants must justify the time-sensitive nature of the ancillary study and the need for an expedited review and award process.
Applicants must also document permission from the parent project to use the patient cohorts, data, and biological materials.
The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects.
Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research communitys understanding of a disease or organ system in the NIAMS portfolio, and thus may identify novel targets for diagnosis, treatment, and prevention of disease.
Related Programs
Arthritis, Musculoskeletal and Skin Diseases Research
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: Not Available
Office: National Institutes of Health
Estimated Funding: Not Available
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-17-003.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-17-003.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2016-02-05
Application Due Date:
2017-04-03
Archive Date:
2017-05-04
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
